Objective Criteria ID Those With No Chance of Survival in OHCA

Share this content:
Objective Criteria ID Those With No Chance of Survival in OHCA
Objective Criteria ID Those With No Chance of Survival in OHCA

TUESDAY, Sept. 13, 2016 (HealthDay News) -- For patients with out-of-hospital cardiac arrest (OHCA), objective criteria enable early identification of those with no chance of survival, according to research published online Sept. 13 in the Annals of Internal Medicine.

Patricia Jabre, M.D., Ph.D., from the Paris Cardiovascular Research Center, and colleagues examined objective criteria for identifying patients with OHCA with no chance of survival during the first minutes of cardiopulmonary resuscitation. Retrospective data from two registries and one trial were reviewed for 1,771 patients from the Paris Sudden Death Expertise Center (SDEC) prospective cohort and for 5,192 patients from validation cohorts. The authors evaluated thee objective criteria: OHCA not witnessed by emergency medical services personnel, nonshockable initial cardiac rhythm, and no return of spontaneous circulation before receipt of a third dose of epinephrine.

The researchers found that the survival rate among 772 patients with OHCA who met the objective criteria was 0 percent in the Paris SDEC one-year cohort (specificity, 100 percent; positive predictive value, 100 percent). In the validation cohorts these results were verified. Twelve percent of patients from the Paris SDEC one-year cohort may have been eligible for organ donation.

"The three objective criteria enable the early identification of patients with OHCA with essentially no chance of survival and may help in decision making about the organ donation process," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Actemra to Treat Giant Cell Arteritis

FDA Approves Actemra to Treat Giant Cell Arteritis

New indication provides the first FDA-approved therapy specific to this type of vasculitis

Trends in Teen Binge Drinking Still Raise Concerns

Trends in Teen Binge Drinking Still Raise Concerns

Even though frequent binge drinking among adolescents has dropped in past 25 years

ATS: First Abx Rx Doesn't Work for 25 of Pneumonia Cases

ATS: First Abx Rx Doesn't Work for ~25% ...

One in four adult patients do not respond to initial prescription of antibiotic treatment

is free, fast, and customized just for you!

Already a member?

Sign In Now »